Inari Medical Inc (NARI)
41.20
+0.52
(+1.28%)
USD |
NASDAQ |
Sep 27, 16:00
41.14
-0.06
(-0.16%)
Pre-Market: 20:00
Inari Medical Research and Development Expense (TTM): 96.17M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 96.17M |
| March 31, 2024 | 92.35M |
| December 31, 2023 | 87.53M |
| September 30, 2023 | 85.05M |
| June 30, 2023 | 82.67M |
| March 31, 2023 | 80.15M |
| December 31, 2022 | 74.22M |
| September 30, 2022 | 72.54M |
| June 30, 2022 | 65.93M |
| March 31, 2022 | 58.99M |
| Date | Value |
|---|---|
| December 31, 2021 | 51.02M |
| September 30, 2021 | 38.83M |
| June 30, 2021 | 31.55M |
| March 31, 2021 | 23.54M |
| December 31, 2020 | 18.40M |
| September 30, 2020 | 14.57M |
| June 30, 2020 | 11.08M |
| March 31, 2020 | 9.029M |
| December 31, 2019 | 7.220M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
7.220M
Minimum
Dec 2019
96.17M
Maximum
Jun 2024
52.68M
Average
58.99M
Median
Mar 2022
Research and Development Expense (TTM) Benchmarks
| Nevro Corp | 55.29M |
| Inspire Medical Systems Inc | 117.90M |
| Axonics Inc | 41.73M |
| Electromed Inc | 0.656M |
| Myomo Inc | 3.559M |